BILL brings AI-powered innovation across payments, AP, and spend management to streamline financial workflows, while Rillet remains the single source of truth for the general ledger and accounting fields. Together, the platforms deliver a seamless, end-to-end finance workflow built for speed, accuracy, and visibility. "BILL powers nearly half a million businesses and has become the backbone of intelligent financial operations,†said Nic Kopp, CEO and founder of Rillet. "When you combine that scale and expert ...

BEVERLY HILLS, Calif.--(BUSINESS WIRE)---- $KW--Kennedy-Wilson, Inc. (the "Issuer†), a wholly-owned subsidiary of global real estate investment company Kennedy-Wilson Holdings, Inc. (the "Company†or "Kennedy Wilson†), today announced that it has commenced offers to exchange (the "Exchange Offers†) any and all of its outstanding 4.750% Senior Notes due 2029 (the "Existing 2029 Notes†), 4.750% Senior Notes due 2030 (the "Existing 2030 Notes†) and 5.000% Senior Notes due 2031 (the "Existing 2031 Note ...

TORONTO, ON / ACCESS Newswire / March 2, 2026 / NextSource Materials Inc. (TSX:NEXT)(OTCQB:NSRCF) ("NextSource" or the "Company") announces that Mr. Jaco Crouse has resigned from his position as Chief Financial Officer after accepting a senior role with another organization. ...

Natural gas prices soared after QatarEnergy halted LNG production following a drone attack on its Ras Laffan complex, increasing worries about supplies through the Strait of Hormuz. ...

Exxon Mobil (NYSE:XOM) shares surged in premarket trading Monday morning as escalating U.S.-Iran military conflict sent crude oil prices sharply higher, igniting a broad rally across the energy sector. The geopolitical shock, triggered by attacks on vessels near the Strait of Hormuz and wider regional strikes, injected a significant risk premium into oil markets, pushing Brent crude up as much as 13% and WTI over 12% intraday. The catalyst behind Monday's move is a dramatic escalation in U.S.-Iran hostiliti ...

Core Insights - Silicon Labs has expanded its Hyderabad facility by 50%, enhancing its global wireless R&D capabilities and emphasizing U.S.-India innovation ties [1] - The expansion includes new labs and operational space to support growth in engineering and global wireless innovation [1] Company Expansion - The expanded facility is designed to support continued hiring and long-term innovation scaling [1] - The new infrastructure includes advanced labs for wireless design, validation, and system integration [1] - Since 2020, Silicon Labs has tripled its India-based workforce, enhancing its technical and operational capabilities [1] Leadership and Collaboration - The grand opening was attended by U.S. Consul General Laura E. Williams, highlighting the importance of U.S.-India economic and technology collaboration [1] - Silicon Labs executives present included President and CEO Matt Johnson, CFO Dean Butler, and Senior VP of Software Development Manish Kothari [1] Strategic Importance - The Hyderabad site plays a central role in global product development, engineering execution, and operational excellence [1] - The expansion positions Silicon Labs to accelerate innovation and attract top engineering talent in response to growing demand for secure, intelligent wireless connectivity [1]

WESTLAKE, Texas--(BUSINESS WIRE)--The Charles Schwab Corporation (Schwab) today announced that it has completed its acquisition of Forge Global Holdings, Inc. (Forge). Forge provides eligible investors with direct and indirect access to shares of pre-IPO companies through direct private share purchases, single company funds, and multicompany funds. The transaction brings together leaders in public markets and private marketplace transactions, and the combination positions Schwab to offer a best-in-class exp ...

Core Viewpoint - Moderna's shares increased by approximately 4% following the EMA's CHMP recommendation for marketing authorization of its mRNA-based combination vaccine, mCombriax, targeting COVID-19 and influenza [1][9]. Group 1: Regulatory Approval Process - The CHMP's recommendation will be reviewed by the European Commission, with a final decision anticipated soon [2]. - If approved, mCombriax will be Moderna's fourth marketed product in the EU, following two COVID-19 vaccines and an RSV vaccine [2]. Group 2: Clinical Study Results - The recommendation was supported by data from a pivotal phase III study that met its primary endpoints, showing that a single dose of mCombriax produced higher immune responses against COVID-19 and influenza compared to standalone vaccines [3][9]. - The study involved around 8,000 adults, split into two age cohorts: one for adults aged 65 and older and another for those aged 50 to 64, comparing mCombriax with existing influenza vaccines [4]. Group 3: Stock Performance - Year-to-date, Moderna's stock has surged approximately 82%, significantly outperforming the industry average growth of 10% [7]. Group 4: Product Details and Future Filings - mCombriax combines Moderna's mNexspike and mRNA-1010, an investigational influenza vaccine, with regulatory filings currently under review in multiple regions including the US, Europe, Canada, and Australia [8]. - A final decision by the FDA regarding mCombriax is expected by August 5, 2026 [8]. Group 5: FDA Review and Challenges - Moderna had previously submitted a regulatory filing for mCombriax to the FDA, which was voluntarily withdrawn in May 2025 due to requests for additional efficacy data for the flu component [10]. - The FDA initially refused to review the mRNA-1010 filing but later reversed its decision after Moderna proposed an age-based regulatory pathway for approval [11].

Group 1 - The coupon rates for floating-rate bonds issued by Nykredit Realkredit A/S will be adjusted effective from 4 March 2026 [1] - The new coupon rates will apply from 4 March 2026 to 4 June 2026 for various bonds with different maturities [2] - Specific new rates include: - DK0030554423 (maturity in 2028) at 2.6440% per annum - NO0013698886 (maturity in 2030) at 5.1000% per annum - NO0013698894 (maturity in 2031) at 5.1700% per annum - NO0013708826 (maturity in 2028) at 4.7700% per annum [2]

Lone Star Funds Completes Sale of SPX FLOW to ITT Inc.Mar 2, 2026 8:50 AM Eastern Standard Time# Lone Star Funds Completes Sale of SPX FLOW to ITT Inc.Share---DALLAS & NEW YORK & LONDON & TOKYO--([BUSINESS WIRE])--Lone Star Funds ("Lone Star†) today announced that an affiliate of Lone Star Fund XI, L.P. has successfully completed the sale of SPX FLOW, Inc. ("SPX FLOW†), a leading provider of highly engineered equipment and process technologies for attractive end markets including industrial, health and ...